ABBV Ex-Dividend Date & Dividend Calculator

AbbVie Inc. (ABBV) is a dividend-growth name with a track record of steady dividend increases, currently paying a quarterly distribution at a yield of 2.7%. The annual growth rate of the dividend matters more than the absolute yield for long-run compounding. Combined with a dividend-reinvestment (DRIP) strategy, long-term portfolio income can grow substantially.

For dividend-growth names, a track record of maintaining or raising the dividend even through recessions is a key selection criterion. Check dividend continuity and payout ratio together. See the complete dividend-types guide and the full dividend-dates guide.

Selection criteria — ABBV is a pharmaceutical company built primarily around biologic drugs such as Humira. It's an individual company with a long history of maintaining and raising its dividend.

Payout mechanics — The listed yield is 2.7% (as of 2026.09.06), paid quarterly. It looks smaller next to high-yield and covered-call names, but payments has stayed very stable payment to payment (variability score 0.04) — a hallmark of this category. The per-payment amount is about $1.7300, paid roughly 4 times a year. This figure is recalculated every period, so it isn't guaranteed to hold going forward — it's a reference point based on past payment history. ABBV's $1.7300 per-payment figure is a snapshot, not a recommendation — weigh it against your own research before acting.

Risk to watch — A lower headline yield doesn't mean weaker dividend capacity; the annual growth rate of the payout is the key variable for long-run compounding in this category. This isn't an estimate — 2026-07-15 is the confirmed next ex-dividend date, and you need to hold through the prior close to qualify. Read dividend-growth investing basics and DRIP reinvestment strategy, then check compounding effects in the 5-year simulator. When making decisions about ABBV, it's safer to treat the $1.7300 figure above as one reference among several rather than the sole basis.

Summary — Annualizing AbbVie Inc.'s ($1.7300) per-payment amount at 4 payments a year comes to roughly $6.92. The actual amount can change every period, so this figure isn't guaranteed. On the stability side, ABBV's recent payments haven't varied enough to trigger the variable-dividend classification. It's also worth factoring in that payments has stayed very stable payment to payment (variability score 0.04) period to period. Every figure on this page is a snapshot as of now and may change at the next refresh. ABBV's $1.7300 per-payment figure is a snapshot, not a recommendation — weigh it against your own research before acting.